ABCB1 and carcinoma: In addition to genetically modified cells, two human carcinoma cell lines (HCT-8 and HepG2, derived from ileocecal adenocarcinoma and Caucasian hepatocyte carcinoma, respectively) were included in these studies since they abundantly express ABCB1 [24] and represent more clinically relevant settings than MDCK cells lines.